Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Viking Scientific Inc. has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This action is assigned to MERCIER, MELISSA S, who is the 1 examiner currently reviewing the company's pending applications. The prosecution is restricted to 1 distinct art unit, pointing to a specific technical focus for this pending matter. For a practitioner, the presence of 1 pending office action means the current administrative burden is low. MERCIER, MELISSA S, as the busiest examiner with 1 pending action, is the primary contact for the company's current USPTO interactions.
This concentrated profile allows for a highly targeted prosecution strategy without the need to manage multiple examiner preferences or art unit variations. Practitioners can benefit from this concentration by focusing all resources on the specific requirements of the 1 distinct art unit involved. The lack of multiple pending actions reduces the complexity of managing the portfolio but places high importance on the outcome of this 1 matter. Establishing a rapport with MERCIER, MELISSA S may be the most effective way to advance the company's current interests in the Biotechnology & Pharmaceuticals sector.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MERCIER, MELISSA S | 1 | 72.1% | +5.8% |
| Art Unit | Apps |
|---|---|
| 1615 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18813757 | HYDROGEL PRODRUG FOR TREATMENT | MERCIER, MELISSA S | 1615 | DP | Non-Final OA | — | Pending | Aug 23, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialViking Scientific Inc. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Melissa S Mercier has the most, with 1 of Viking Scientific Inc.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
